Key Takeaways
- Fragrance division is the growth engine: The division had a very good year, winning new business internationally and domestically even as the Indian FMCG sector slowed, and management sees a healthy order pipeline ahead.
- Camphor division traded volume for margin: Management consciously reduced production to avoid uneconomical pricing, protecting the business; by H2, market conditions stabilized and cautious optimism is returning.
- Mahad greenfield is the margin drag: The newly commissioned plant posted a net loss of ₹5.9 crore in Q4 and ₹11.74 crore for FY25, the primary reason for a 1.35% EBITDA reduction at the consolidated level.
- Working capital rose by design: Higher inventories were a strategic call because raw material prices were at multi-year lows, a bet management expects will deliver value as prices rise.
- What to watch next quarter: The pace of Mahad’s ramp-up toward its 1.4–1.5x turnover target, whether camphor pricing uptick materializes into margin, and any tariff-driven advantage over China.
Fragrance: The Standout Performer
- Broad-based growth despite FMCG headwinds: The division grew by winning new international and domestic business, expanding footprint with global clients, adding new Indian customers in personal care, home care and air care, and deepening share of wallet with existing clients. Smaller and regional customers also added significant volumes.
- Backward integration as a competitive lever: OAL is among the few fragrance houses that manufactures its own aroma ingredients, which in FY25 ensured supply security, cost control, and the flexibility to price competitively without compromising quality when global supply chains were unpredictable.
- Demand normalization after destocking: Large FMCG customers globally and in India had reduced fragrance inventories built up during prior supply chain disruptions, causing a short-term order dip in H1. By year-end, order patterns normalized as client inventories reached equilibrium.
- Pipeline supports continued momentum: Both domestic FMCG clients and international buyers have provided encouraging forecasts; creative teams are working on new fragrance briefs expected to translate into business.
Shyamal Bodani: "We consciously traded off some top line growth in exchange for healthier margin and a stronger foundation. This prudence aligns with our long term view for the business, and we anticipated that as the cycle turns, Oriental Aromatics will be well positioned to capture the upside in camphene and terpene chemicals."
Camphor & Terpene Chemicals: A Year of Consolidation
- Volume sacrificed to protect value: Management adopted a strategy to preserve value amid pricing pressure, in some cases reducing production volumes to focus on higher margin sales rather than chasing unsustainable volumes at low margins. Sales volumes were flat YoY and overall revenue subdued, but the approach avoided flooding the market.
- Brand internalization creates a strategic moat: The Saraswati and 3 Pine brands, now fully managed by dedicated OAL teams after moving from a franchise model, consume 60% of camphor powder production internally. The realization on branded camphor is at an advantage to selling powder, insulating the company from challenging powder pricing even with expanded domestic capacity.
- Stabilization and cautious optimism: By H2, the strategy began to pay off as market conditions stabilized. In Q4 and towards year-end, there was an uptick in order inquiries for certain terpene specialties, and some success in export markets. Management is cautiously optimistic, seeing an uptick in pricing.
- Competitive landscape remains tough: The market remains oversupplied with demand growing steadily; without certain strategic levers, sustainable profit margins will always be challenging. The remaining 40% of camphor output goes to the pain management pharma space and very limited powder sales to select geographies that do not compete with own brands.
- Internal consumption ambition: Management flagged that taking internal camphor consumption from 60% to 75% in the years ahead would be interesting to watch for its margin impact.
Management: "That was in my opening speech where, it's a moat for us, because 60% we consume internally for our two brands. So even with the expanded capacity in the country, we currently stay relatively insulated from it."
Mahad: The Investment Phase Drag
- Commissioned but loss-making: Full commercial production commenced November 12, 2024. The subsidiary posted a net loss of ₹5.9 crore in Q4 and ₹11.74 crore for FY25, the primary reason for a 1.35% reduction in consolidated EBITDA.
- Ramp-up is a multi-quarter process: The plant is currently in the sampling and approval phase, building up stocks. Customer evaluation cycles run 100–150 days. Full top-line contribution will reflect in FY26 and beyond.
- Evermoss reception encouraging: Customer feedback for Evermoss has been positive, with global distributors and key clients expressing keen interest. Management describes it as a prime example of moving up the value chain.
- Turnover target set: Management is targeting a conservative turnover ratio of 1.4 to 1.5 on the investment.
- Land bank for future: The Mahad facility can accommodate three more plants the size of Evermoss, with environmental clearance already in place, though near-term CAPEX focus is on stabilization and capacity utilization of existing plants.
Management: "We often speak about process efficiency and moving up the value chain. Evermoss is a prime example of that philosophy in action."
Specialty Aroma Ingredients: Volume Up, Price Under Pressure
- Healthy demand, compressed realizations: The division saw healthy demand and volume growth throughout FY25, with good growth in production and sales volume. However, stiff competition and an oversupplied market for commodity aroma chemicals pressured profitable price realization.
- Specialty shift as the answer: The company responded by emphasizing its specialty portfolio, focusing on niche and high-value aroma chemicals where it has efficient processes or quality advantages. Backward integration allowed internal consumption of a sizable portion of output at transfer prices, securing assured margins.
- Stabilization visible: The first basket of products, excluding Mahad, is mostly out of the 100-day customer evaluation cycle; growth has returned to a stable level and volume is expected to go up. By year-end there were early signs that raw material cost inflation was easing.
Margins: Compression with a Recovery Path
- Gross margin dipped on one-offs and input costs: Gross margin compressed to 38% from 40% QoQ, driven by one-time sales promotion expenses including global and national exhibitions, and an increasing trend in some raw material prices. Management expects gross margin to stay at the 39–40% level.
- EBITDA guidance held at 10–12%: Management stuck to its 10–12% EBITDA margin guidance, with a philosophy to "under commit and over deliver." If an opportunity to improve arises from internal or external factors, they will update the investor community.
- Mahad is the structural drag: The ₹11.74 crore FY25 net loss from the Mahad subsidiary is the primary consolidated margin headwind; as the plant ramps up toward its turnover target, this drag should reduce.
- Working capital bet on raw materials: The strategic decision to hold higher inventories across all divisions was driven by raw material prices at multi-year lows, with management expecting these inventory positions to deliver value as prices rise in coming quarters. Some marquee customers extended payments beyond stipulated periods, pressuring receivables, but they are course-correcting.
Management: "it's our approach and our philosophy that we want to be cautiously optimistic and keep it in the 10 to 12 range and try to get it better and under commit and over deliver."
Strategic Levers & External Tailwinds
- Brand internalization completed: Saraswati and 3 Pine camphor brands, with a pan-India presence and over 60% of total powder camphor production, are now fully managed by dedicated OAL teams after moving from a franchise model. The brands serve as a national launch pad for deeper expansion into India's puja segment.
- Backward and forward integration: The company is committed to leveraging backward integration to help the fragrance division while pursuing forward integration through internalizing brands. Every new product launch initiates activity in the creative division to use it more internally.
- Tariff opportunity: If India turns out to be at a strategic advantage over China regarding tariffs, management noted it would be "very, very interesting to see in the coming quarter to come."
- Trading division as a hedge: The newly launched trading division in essential commodities is getting an extremely good response from customers and helps lower the overall cost of buying imported raw materials for the fragrance division.
- CAPEX discipline: The strategic focus is now on stabilization, capacity utilization, and capacity selling of all plants. Future CAPEX will only be undertaken when very specific targeted opportunities arise.
Parag Satoskar: "When it came to the fragrance division we were seeing certain aroma chemicals and essential oils which were at their lowest levels ever. So, it was a strategic decision to probably maintain a bit of higher inventories there."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin | 10% to 12% range | Ongoing (no change from prior year) |
| Gross margin | 39% to 40% level | Ongoing |
| Mahad top-line contribution | Full contribution to reflect | FY26 and beyond |
| Mahad turnover ratio | Conservative 1.4 to 1.5x on investment | No specific quarter given |
| Volume growth (aroma chemicals & F&F) | Double-digit | Targeted |
| Volume growth (camphor) | Single-digit or steady | Targeted |
| Future CAPEX | Only when very specific targeted opportunities arise; focus on stabilization and capacity utilization of existing plants | Near term |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Operating revenue | ₹253 crore, +17% YoY and +13.7% QoQ |
| EBITDA | ₹19 crore, vs ₹22 crore in Q3 FY25 and ₹20.9 crore in Q4 FY24 |
| EBITDA margin | 7.62%, vs 10.15% in Q3 FY25 |
| Net profit after tax | ₹1.4 crore |
| Gross margin | ~38%, compressed from 40% in Q3 FY25; raw material price increases and one-time sales promotion expenses cited |
| FY25 operating revenue | ₹928 crore, +11% YoY |
| FY25 EBITDA | ₹93.4 crore, nearly doubling YoY |
| FY25 EBITDA margin | 10.06%, up from 5.62% in FY24 |
| FY25 net profit after tax | ₹34.3 crore, up from ₹9.1 crore in FY24 |
| FY25 PAT margin | 3.69%, +260 bps YoY |
| FY25 cash profit | ₹58 crore, vs ₹28.9 crore in FY24 |
| FY25 return on capital employed | 9.33%, vs 3.90% in FY24 |
| Mahad subsidiary loss | ₹5.9 crore in Q4, ₹11.74 crore in FY25; primary reason for 1.35% reduction in consolidated EBITDA |
| EBITDA margin guidance | 10% to 12%, management reaffirmed |
| Camphor and terpene sales volumes | Flat YoY for FY25 |
| Powder camphor internal consumption | 60% of total production, consumed by Saraswati and 3 Pine brands |
| Revenue mix by division | ~one-third each: camphor and terpene chemicals, specialty aroma ingredients, fragrance and flavor |
| Mahad Evermoss initial capacity | 250 metric tons |
| Export exposure | 46% of total revenue |